GMP Cell Therapy Consumables Market

The global GMP Cell Therapy Consumables Market is valued at USD 15.05 Million in 2024 and is projected to reach a value of USD 114.4 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 28.9% between 2025 and 2035.

The GMP Cell Therapy Consumables market is driven by rising demand for advanced therapies, increasing investments in cell therapy research, and a growing prevalence of chronic diseases that require innovative treatment options. Moreover, advancements in technology and the expansion of manufacturing capabilities are anticipated to further boost GMP Cell Therapy Consumables market industry growth.

Drug discovery is a substantial journey that encompasses several stages, including initial discovery, preclinical trials, clinical studies, and regulatory approval. This complex process heavily relies on cell therapy consumables to obtain optimal results. The World Health Organization (WHO) reported approximately 10 million cancer-related deaths in 2020, with the most prevalent types being breast, lung, colon, rectal, and prostate cancers.

Key Highlights

• Based on the Product Type, the Cell Culture media and Supplements category accounted for significant market share in GMP Cell Therapy Consumables market industry for 41.40% in 2024
• In 2024, Based on Cell Type, Stem Cells dominated the GMP Cell Therapy Consumables market with market share of 41.80%
• Based on the Application, the Oncology category accounted for significant market share in GMP Cell Therapy Consumables market industry for 44.50% in 2024
• By End Users, Hospitals and Clinics dominated the GMP Cell Therapy Consumables market industry with market share
• North America dominated the GMP Cell Therapy Consumables market industry with 42.60% GMP Cell Therapy Consumables market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period in GMP Cell Therapy Consumables market industry

Product Type Overview

The Product Type segment is divided into Cell Culture media and Supplements, Cell Separation and Purification Consumables, Cryopreservation Consumables, Cell Transduction Consumables, Other Consumables. The Cell Culture media and Supplements segment held the GMP Cell Therapy Consumables market size of 41.40% in 2024.

Cell culture media and supplements play a crucial role in tissue engineering, regenerative medicine research, and the production of downstream cell therapies. All cell-based applications necessitate specialized nutrient solutions to facilitate the growth and maintenance of cells in vitro, outside of their natural environments. Various cell types have distinct nutrient needs that must be addressed through tailored media formulations, which are essential for promoting cell proliferation, metabolism, phenotype expression, and other critical functions.

Cell separation and purification consumables are essential components of the GMP Cell Therapy Consumables market, used to isolate and purify specific cell types. Key consumables include chromatography columns, centrifugation tubes, magnetic separation beads, filtration devices, and microbeads for cell labeling. The segment is driven by growing demand for cell therapies, advancements in cell therapy technologies, and stringent regulatory requirements. Challenges include high costs and limited availability of some consumables.

Cryopreservation consumables are essential for preserving the viability and function of cells during storage.Key consumables include cryovials, cryopreservation bags, freezing containers, and controlled-rate freezers. These consumables help maintain optimal cooling and thawing rates, minimizing cell damage. The GMP Cell Therapy Consumables Market industry for cryopreservation consumables is driven by the growing demand for cell therapies and the need for long-term storage of cells.

Cell Type Overview

​The Cell Type segment is divided into Stem Cells, T-Cells, Natural Killer Cells, Other Cell Types. The Stem Cells segment held the dominant share in 2024, accounting for significant GMP Cell Therapy Consumables industry share of 41.80%.

Stem cell therapies, utilizing sources like mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) from bone marrow, cord blood, or adipose tissue, show promise in treating various conditions. As these therapies evolve in complexity and standardization, advanced cell separation and purification consumables become crucial. Ensuring the safety and efficacy of these therapies mandates high levels of cell purity, viability, and functionality. Chromatographic columns, centrifugation tools, surface marker microbeads, and other single-use separation consumables streamline processing while minimizing the risk of contamination.

T-cell therapy is an immunotherapy used to treat certain types of cancer, especially blood cancer or leukemia. The therapy capitalizes the power of immune system protecting against the infections and illnesses by destroying harmful invaders, such as viruses and bacteria. Various research and clinical trials on CAR T-cell therapy are being conducted for cancer treatment. For instance, In January 2022, A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase I clinical trial of patients at University College London Hospitals (UCLH).

Application Overview

​The Application segment is divided into Oncology, Regenerative Medicine, Neurology, Cardiovascular, Immunology, Other Application. The Oncology segment held the dominant share in 2024, accounting for significant GMP Cell Therapy Consumables industry share of 44.50%.

The oncology segment is a major driver of the GMP Cell Therapy Consumables market due to extensive global research efforts and the burgeoning field of cell-based cancer treatments. Adoptive cell therapies, which utilize engineered T cells, natural killer cells, tumor-infiltrating lymphocytes, and other immunotherapies, hold immense promise based on early successes against both hematological and solid tumor types, such as melanoma. The increasing use of cell immunoprofiling and ex vivo drug sensitivity testing to personalize precision oncology regimens further solidifies oncology's position as a leading clinical user of advanced cell therapy consumables.

End User Overview

​The End User segment is divided into Biopharmaceutical Companies, Contract Manufacturing Organization (CMO), Academic and Research Institution, Hospitals and Clinics, Others. The Hospitals and Clinics segment held the dominant share in 2024, accounting for significant GMP Cell Therapy Consumables industry share.

In Hospital and clinical use, cell therapy research is carried out on people to evaluate medical, surgical, or behavioral intervention of a particular therapy. The segment is driven by increasing clinical trials in hospitals due to high prevalence of chronic diseases, rising clinical studies and research efforts for developing new cell therapies are expected to enhance the GMP Cell Therapy Consumables market size over the upcoming years.

Regional Overview

In 2024, the GMP Cell Therapy Consumables market size of the North America is USD 6.4 Billion.

North America GMP Cell Therapy Consumables industry report is driven by a increasing demand for cell therapies, the surging use of GMP cell therapy consumables, and rising research efforts in drug discoveries. The presence of major market players and increased funding for cell-based research projects in the region. Furthermore, supportive regulatory environment provided by U.S. FDA and increased funding for cell-based research activities have accelerated product development in North America.

U.S. GMP Cell Therapy Consumables Market Analysis

In 2024, the U.S. led the North American GMP Cell Therapy Consumables Market, driven by a strong presence of leading pharmaceutical and biotechnology companies, a supportive regulatory environment, and significant funding for cell therapy research. Additionally, the U.S. boasts a supportive regulatory environment, with the FDA actively facilitating the development and approval of novel cell therapies. This, coupled with significant government and private funding for cell-based research activities, fosters a dynamic ecosystem that accelerates product development and fuels demand for high-quality consumables.

Asia Pacific GMP Cell Therapy Consumables Market Analysis

The Asia Pacific GMP Cell Therapy Consumables industry report is set for significant growth with over the forecast period fueled by factors such as rising healthcare infrastructure, and increasing investments in cell therapies. Countries like China, Japan, South Korea, and India exhibit significant potential in the GMP Cell Therapy Consumables market. This growth is fueled by increased healthcare investments, a thriving biopharmaceutical industry, and a large patient population grappling with chronic diseases. Government initiatives aimed at boosting domestic manufacturing and streamlining regulatory frameworks are creating a favorable environment for both domestic and international companies. The region's appeal as a manufacturing hub is further enhanced by lower production costs and readily available low-cost raw materials.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

GMP Cell Therapy Consumables Market Trends

1. Technological advancements: Ongoing innovations in cell processing technologies, such as automated cell processing platforms, single-use systems, and advanced bioreactors, are driving the demand for specialized consumables
2. Personalized medicine: The increasing focus on personalized medicine and the development of cell therapies tailored to individual patients are creating a need for high-quality, customizable consumables
3. Expansion of cell therapy applications: The expanding scope of cell therapy applications, beyond oncology, into areas such as regenerative medicine, immunology, and infectious diseases, is creating new market opportunities for consumables
4. Stringent regulatory requirements: The increasing emphasis on quality and safety by regulatory bodies worldwide is driving the demand for high-quality, GMP-compliant consumables
5. Consolidation of the market: The market is witnessing a trend towards consolidation, with large players acquiring smaller companies to expand their product portfolios and market share

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Market Drivers for GMP Cell Therapy Consumables Market

Increasing investment in cell-based research

The GMP Cell Therapy Consumables market is experiencing significant growth driven by substantial investments in cell-based research initiatives. Biotech and pharmaceutical companies are increasing their R&D expenditures to develop innovative cell-based therapies for a wide range of medical conditions. The flourishing fields of stem cell research and regenerative medicine are also attracting substantial investments from both public and private sectors. In response to the growing demand from cell therapy clinical trials and research projects, leading consumable suppliers are expanding their product portfolios and production capacities. This dynamic is further evidenced by the increasing number of collaborations between consumable suppliers and cell therapy developers.

Market Challenges for GMP Cell Therapy Consumables market

The growth of the GMP Cell Therapy Consumables market may be hindered by the high costs associated with cell therapies. The development and manufacturing of cell therapies necessitate specialized facilities, highly skilled personnel, and expensive equipment. The intricate production process, encompassing steps such as cell extraction, processing, culture media preparation, and final formulation, significantly increases the overall cost of developing a single cell therapy. As cell therapies are personalized medicines developed for relatively small patient populations, the high manufacturing costs cannot be distributed across a large volume of products.

Competitive Landscape

The GMP Cell Therapy Consumables market report is characterized by the presence of both established players and emerging companies, each strive for market share through product innovation, strategic partnerships, and geographic expansion. Industry giants like Thermo Fisher Scientific Inc, Lonza Group, Merck KGaA, Corning Inc, Sartorius AG, Danaher Corporation, GE Healthcare, HiMedia Laboratories, Beckman Coulter Inc, Avantor Inc, Bio-Techne Corporation, Stemcells Technologies Inc. These companies are actively investing in innovative technologies and expanding their product offerings to cater to the evolving needs of the GMP Cell Therapy Consumables market industry. However, the market also features several smaller players and emerging companies that are developing niche technologies and innovative solutions.

The key players in the global GMP Cell Therapy Consumables market report include - Thermo Fisher Scientific Inc, Lonza Group, Merck KGaA, Corning Inc, Sartorius AG, Danaher Corporation, GE Healthcare, HiMedia Laboratories, Beckman Coulter Inc, Avantor Inc, Bio-Techne Corporation, Stemcells Technologies Inc among others.

Recent Market Developments

Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production

• In April 2024, Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 (CTS Detachable Dynabeads). These latest products expand on Thermo Fisher’s CTS Detachable Dynabeads platform, which represents a new generation of cell therapy isolation and/or activation products that prioritize cell quality while also creating greater workflow control. Ultimately, these products can help customers maximize the potential of their therapies to save more lives

Sony Introduces New Closed Cell Isolation System CGX10 for use in Production of Advanced Cell Therapy Products

• In January 2022, Sony Corporation ("Sony") today introduced a new Cell Isolation System, CGX10, which sorts cells at high speed and high purity in a closed system. The CGX10's design enables sorting of cells in a manner that is designed to be closed off from the outside environment, making it possible to analyze and isolate cells while maintaining a sterile state

The global GMP Cell Therapy Consumables market can be categorized as Product Type, Cell Type, Application, End-User and Region.